C2244

C2244 is a monoclonal antibody biosimilar expressed in CHO cells, targeting IL1RL1/ST2, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Recombinant Human Antibody (C2244) is capable of binding to ST2L, expressed in HEK 293 cells. Expressed as the combination of a heavy chain (HC) containing VH from anti-ST2L mAb and CH1-3 region of human IgG1 and a light chain (LC) encoding VL from anti-ST2L proteins mAb and CL of human kappa light chain. Exists as a disulfide linked dimer of the HC and LC hetero-dimer under non-reducing condition.

Target	IL1RL1/ST2
Clonality	Monoclonal
Reactivity	Human
Expression	Recombinant
Tested Applications	ELISA, WB
Host	Human
Recommended dilutions	Optimal dilutions/concentrations should be determined by the end user.
Conjugation	Unconjugated
Isotype	IgG
Form	Liquid
Purity	> 95%
Purification	Purified from cell culture supernatants by Protein A/G chromatography.
Storage	Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Buffer	0.01 M PBS. pH 7.4.
Concentration	Batch-dependent, typically between 0.5-2.0 mg/ml.
Availability	Shipped within 7-12 working days.
Note	This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use.

Research Articles on IL1RL1/ST2

Write a review

Your Name

Your Email Address

PMID

DOI

Your Review

Rating

Continue